We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.89%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$74.4B
AUM Growth
+$7.26B
Cap. Flow
+$2.46B
Cap. Flow %
3.31%
Top 10 Hldgs %
19.47%
Holding
3,107
New
25
Increased
2,535
Reduced
421
Closed
97

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$141M
2
AAPL icon
Apple
AAPL
+$117M
3
ACWX icon
iShares MSCI ACWI ex US ETF
ACWX
+$96.6M
4
AMZN icon
Amazon
AMZN
+$63.7M
5
PLD icon
Prologis
PLD
+$47.7M

Sector Composition

Rank Sector Weight
1 Technology 22.05%
2 Healthcare 14.94%
3 Financials 14.18%
4 Consumer Discretionary 10%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DBRG icon
1601
DigitalBridge
DBRG
$2.95B
$2.87M ﹤0.01%
262,521
+9,894
+4% +$129K
RPT
1602
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$2.87M ﹤0.01%
285,988
+12,344
+5% +$122K
CCSI icon
1603
Consensus Cloud Solutions
CCSI
$647M
$2.87M ﹤0.01%
53,334
+1,134
+2% +$61.8K
CNK icon
1604
Cinemark Holdings
CNK
$4.32B
$2.86M ﹤0.01%
330,369
+23,233
+8% +$262K
CCRN
1605
DELISTED
Cross Country Healthcare
CCRN
$2.85M ﹤0.01%
107,395
-524
-0.5% -$17.1K
NNI icon
1606
Nelnet
NNI
$4.7B
$2.85M ﹤0.01%
31,415
+103
+0.3% +$9.34K
NOVA
1607
DELISTED
Sunnova Energy
NOVA
$2.84M ﹤0.01%
157,594
+3,443
+2% +$69.3K
AKRO
1608
DELISTED
Akero Therapeutics
AKRO
$2.83M ﹤0.01%
51,713
+9,452
+22% +$405K
DCH
1609
Dauch Corp
DCH
$1.51B
$2.83M ﹤0.01%
362,333
+6,136
+2% +$55K
NOG icon
1610
Northern Oil and Gas
NOG
$2.35B
$2.83M ﹤0.01%
91,811
+3,521
+4% +$118K
BANC icon
1611
Banc of California
BANC
$2.97B
$2.83M ﹤0.01%
177,558
+4,733
+3% +$77.3K
RVMD icon
1612
Revolution Medicines
RVMD
$44B
$2.83M ﹤0.01%
118,737
+10,635
+10% +$226K
VECO icon
1613
Veeco
VECO
$3.23B
$2.81M ﹤0.01%
151,075
+7,903
+6% +$149K
INVX
1614
Innovex International
INVX
$1.97B
$2.81M ﹤0.01%
103,230
-2,906
-3% -$69.2K
ENTA icon
1615
Enanta Pharmaceuticals
ENTA
$400M
$2.79M ﹤0.01%
60,063
+60
+0.1% +$2.73K
TRST
1616
Trustco Bank Corp NY
TRST
$938M
$2.78M ﹤0.01%
73,993
+5,267
+8% +$192K
FOCS
1617
DELISTED
Focus Financial Partners Inc. Class A
FOCS
$2.78M ﹤0.01%
74,506
+2,076
+3% +$73.9K
ACAD icon
1618
Acadia Pharmaceuticals
ACAD
$5.03B
$2.75M ﹤0.01%
172,882
+5,322
+3% +$83.2K
PRG icon
1619
PROG Holdings
PRG
$1.71B
$2.75M ﹤0.01%
162,717
+2,321
+1% +$39.6K
HCSG icon
1620
Healthcare Services Group
HCSG
$1.53B
$2.73M ﹤0.01%
227,536
+4,103
+2% +$54.2K
OSH
1621
DELISTED
Oak Street Health, Inc.
OSH
$2.73M ﹤0.01%
126,858
+5,845
+5% +$122K
VCYT icon
1622
Veracyte
VCYT
$3.8B
$2.73M ﹤0.01%
114,964
+3,508
+3% +$81.5K
EFSC icon
1623
Enterprise Financial Services Corp
EFSC
$2.39B
$2.73M ﹤0.01%
55,679
+852
+2% +$42.3K
WWW icon
1624
Wolverine World Wide
WWW
$1.55B
$2.72M ﹤0.01%
248,904
+9,449
+4% +$126K
CPA icon
1625
Copa Holdings
CPA
$5.8B
$2.72M ﹤0.01%
32,659
+2,902
+10% +$228K

Similar funds

RhumbLine Advisers's Q4 2022 Portfolio in Review

As of Q4 2022, RhumbLine Advisers held 3,107 positions worth $74.4B, up 11% from $67.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

RhumbLine Advisers deployed $2.46B of net new capital in Q4 2022, opening 25 new positions and adding to 2,535 existing holdings. Its largest new stake was iShares MSCI ACWI ex US ETF: 2,203,118 shares worth $100M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Steel Dynamics, an estimated $18.8M trimmed.

  • RhumbLine Advisers's largest Q4 2022 buy was iShares MSCI ACWI ex US ETF: 2,203,118 shares worth $100M.
  • RhumbLine Advisers added most to Microsoft in Q4 2022, an estimated $141M increase.
  • RhumbLine Advisers's biggest Q4 2022 reduction was Steel Dynamics, cutting an estimated $18.8M.
  • RhumbLine Advisers fully exited Twitter, Inc. in Q4 2022, selling an estimated $56.3M.
  • RhumbLine Advisers's ten largest holdings make up 19% of its $74.4B portfolio in Q4 2022.
  • RhumbLine Advisers opened 25 new positions and closed 97 in Q4 2022.
  • RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $74.4B.

Based on RhumbLine Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.